Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer

PRIMARY OBJECTIVES:

I. Determine any change in pain, fatigue and psychological well-being as a result of SKY in
prostate cancer (PCa) patients.

II. Assess changes in some physiological parameters in response to SKY in the same subjects,
compare these with those from Part 1, and assess whether these translate into clinical
effects.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I (Control Group): Patients undergo collection of blood, saliva, and hair samples after
signing consent (pre-test 1), within 6-8 weeks after pre-test 1 (post-test 1), and within 2-4
months after post-test 1 (post-test 2). Patients may receive yoga instruction for 1 week
after post-test 2.

ARM II (Yoga Group): Patients receive yoga instruction over approximately 3 hours daily for 5
days of week 1 and over 2 hours once a week of weeks 2-13. Patients also undergo collection
of blood, saliva, and hair samples within 2 months prior to starting yoga instruction, within
weeks 2-3, and within weeks 14-15.

Inclusion Criteria:

- Having finished radiotherapy at least two months ago

- Ability to speak and read English and give informed consent

- Have an interest in being part of a study to evaluate yoga-derived exercises and eager
to practice some kind of relaxation exercise daily for 3 months

Exclusion Criteria:

- Have a diagnosis of psychiatric illness or other major illness in addition to PCa,
such as other cancers, uncontrolled hypertension, lung disease, liver disease or heart
disease